Home Page - 2026 Seattle Cellular Therapy Summit

The 2026 Seattle Cellular Therapy Summit is a premier educational event for hematologists, oncologists, transplant specialists, and advanced practitioners. This in-person hematology oncology conference delivers cutting-edge, practical education on the latest advances in cellular therapy, including CAR T-cell treatments, stem cell transplantation, bispecific antibodies, and emerging genetic therapies.

Structured as a dynamic, single-day summit, the program features expert-led presentations and interactive case-based panels focused on the real-world application of these therapies across lymphomas, acute leukemias, plasma cell disorders, and beyond. Emphasis is placed on clinical decision-making, including patient selection, treatment sequencing, toxicity management, and strategies to improve care coordination and accessibility. This conference provides a critical update for clinicians integrating these transformative treatments into practice and anticipating the future of immuno-oncology.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Bell Harbor International Conference Center